nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R2—cerebellum—meningioma	0.00646	0.116	CbGeAlD
Isoprenaline—PIK3R1—medulla oblongata—meningioma	0.0053	0.0952	CbGeAlD
Isoprenaline—PIK3R2—brain—meningioma	0.00525	0.0943	CbGeAlD
Isoprenaline—MAPK1—brainstem—meningioma	0.00518	0.0931	CbGeAlD
Isoprenaline—PIK3R1—spinal cord—meningioma	0.00472	0.0849	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—meningioma	0.00438	0.0788	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—meningioma	0.00374	0.0673	CbGeAlD
Isoprenaline—PIK3R3—brain—meningioma	0.00356	0.064	CbGeAlD
Isoprenaline—MAPK1—spinal cord—meningioma	0.00322	0.0579	CbGeAlD
Isoprenaline—PIK3R1—brain—meningioma	0.00304	0.0547	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—meningioma	0.00259	0.0466	CbGeAlD
Isoprenaline—MAPK1—cerebellum—meningioma	0.00255	0.0459	CbGeAlD
Isoprenaline—ADRBK1—brain—meningioma	0.0021	0.0378	CbGeAlD
Isoprenaline—MAPK1—brain—meningioma	0.00207	0.0373	CbGeAlD
Isoprenaline—ADRB1—brain—meningioma	0.00088	0.0158	CbGeAlD
Isoprenaline—CYP1A1—brain—meningioma	0.000568	0.0102	CbGeAlD
Isoprenaline—ADRBK1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000378	0.0004	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR—AKT1—meningioma	0.000377	0.000399	CbGpPWpGaD
Isoprenaline—PIK3R1—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000377	0.000399	CbGpPWpGaD
Isoprenaline—MAPK1—Integrin-mediated Cell Adhesion—AKT1—meningioma	0.000377	0.000399	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—TSHB—meningioma	0.000376	0.000399	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by ERBB2—AKT1—meningioma	0.000375	0.000397	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—PDGFB—meningioma	0.000373	0.000395	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 signaling—AKT1—meningioma	0.000373	0.000395	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—HES1—meningioma	0.000373	0.000395	CbGpPWpGaD
Isoprenaline—MAPK1—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.000371	0.000393	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000371	0.000392	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by NGF—AKT1—meningioma	0.00037	0.000392	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD34—meningioma	0.00037	0.000392	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000368	0.000389	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000367	0.000388	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—PTEN—meningioma	0.000366	0.000388	CbGpPWpGaD
Isoprenaline—PIK3R2—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000363	0.000384	CbGpPWpGaD
Isoprenaline—MAPK1—ErbB1 downstream signaling—AKT1—meningioma	0.000362	0.000384	CbGpPWpGaD
Isoprenaline—MAPK1—TGF-beta Signaling Pathway—TP53—meningioma	0.000357	0.000378	CbGpPWpGaD
Isoprenaline—MAPK1—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.000357	0.000378	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—TSHB—meningioma	0.000353	0.000374	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CTSL—meningioma	0.000353	0.000374	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—PTEN—meningioma	0.000352	0.000373	CbGpPWpGaD
Isoprenaline—MAPK1—DNA Damage Response (only ATM dependent)—AKT1—meningioma	0.000352	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 interactions—AKT1—meningioma	0.000351	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR in disease—AKT1—meningioma	0.000351	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000351	0.000372	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by EGFR—AKT1—meningioma	0.000348	0.000368	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—TSHB—meningioma	0.000346	0.000366	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by EGFR in Cancer—AKT1—meningioma	0.000345	0.000365	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—PDGFB—meningioma	0.000345	0.000365	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by PDGF—AKT1—meningioma	0.000343	0.000364	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SMO—meningioma	0.000343	0.000364	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—ERBB2—meningioma	0.000343	0.000363	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SMO—meningioma	0.000338	0.000358	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—ERBB2—meningioma	0.000337	0.000357	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by VEGF—AKT1—meningioma	0.000337	0.000357	CbGpPWpGaD
Isoprenaline—PIK3R1—Focal Adhesion—AKT1—meningioma	0.000332	0.000351	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—ERBB2—meningioma	0.000331	0.00035	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PGR—meningioma	0.000329	0.000349	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—ERBB2—meningioma	0.000329	0.000348	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TSHB—meningioma	0.000327	0.000346	CbGpPWpGaD
Isoprenaline—PIK3R1—B Cell Activation—AKT1—meningioma	0.000325	0.000344	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PGR—meningioma	0.000324	0.000343	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HES1—meningioma	0.000321	0.00034	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—TP53—meningioma	0.000321	0.00034	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—TSHB—meningioma	0.000321	0.00034	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—SMO—meningioma	0.00032	0.000339	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TSHB—meningioma	0.000319	0.000338	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HES1—meningioma	0.000317	0.000335	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TSHB—meningioma	0.000314	0.000332	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—PDGFB—meningioma	0.000313	0.000331	CbGpPWpGaD
Isoprenaline—PIK3R1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000311	0.000329	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—PLAU—meningioma	0.000303	0.000321	CbGpPWpGaD
Isoprenaline—MAPK1—TGF-beta Signaling Pathway—AKT1—meningioma	0.000302	0.00032	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CST3—meningioma	0.000301	0.000318	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—ERBB2—meningioma	0.000299	0.000317	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—PDGFB—meningioma	0.000298	0.000315	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000295	0.000313	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by NGF—AKT1—meningioma	0.000295	0.000313	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TP53—meningioma	0.000295	0.000312	CbGpPWpGaD
Isoprenaline—PIK3R1—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000294	0.000311	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—PDGFB—meningioma	0.000293	0.000311	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—PTEN—meningioma	0.000292	0.000309	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by NGF—AKT1—meningioma	0.000291	0.000308	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00029	0.000307	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—PTEN—meningioma	0.000288	0.000305	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by SCF-KIT—AKT1—meningioma	0.000286	0.000303	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—HES1—meningioma	0.000282	0.000299	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—PTEN—meningioma	0.000282	0.000299	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—PDGFB—meningioma	0.000282	0.000298	CbGpPWpGaD
Isoprenaline—MAPK1—BDNF signaling pathway—AKT1—meningioma	0.000281	0.000298	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—PTEN—meningioma	0.000281	0.000297	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SMO—meningioma	0.000278	0.000295	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TP53—meningioma	0.000278	0.000294	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—ERBB2—meningioma	0.000278	0.000294	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PDGFB—meningioma	0.000275	0.000291	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling of activated FGFR—AKT1—meningioma	0.000274	0.00029	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—SMO—meningioma	0.000273	0.000289	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—meningioma	0.000272	0.000288	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SMO—meningioma	0.000272	0.000288	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000271	0.000287	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PDGFB—meningioma	0.000271	0.000287	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB4—AKT1—meningioma	0.00027	0.000285	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—SMO—meningioma	0.000267	0.000283	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PGR—meningioma	0.000267	0.000282	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—ERBB2—meningioma	0.000267	0.000282	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000266	0.000282	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HES1—meningioma	0.00026	0.000276	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PGR—meningioma	0.00026	0.000276	CbGpPWpGaD
Isoprenaline—MAPK1—Insulin Signaling—AKT1—meningioma	0.000259	0.000274	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—AKT1—meningioma	0.000257	0.000273	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—AKT1—meningioma	0.000256	0.000271	CbGpPWpGaD
Isoprenaline—MAPK1—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000256	0.000271	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—AKT1—meningioma	0.000255	0.00027	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—AKT1—meningioma	0.000254	0.000269	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—ERBB2—meningioma	0.00025	0.000265	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—AKT1—meningioma	0.000249	0.000263	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PDGFB—meningioma	0.000241	0.000256	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—PDGFB—meningioma	0.000241	0.000255	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000239	0.000253	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—AKT1—meningioma	0.000239	0.000253	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000239	0.000253	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—AKT1—meningioma	0.000239	0.000253	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—AKT1—meningioma	0.000239	0.000253	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—PTEN—meningioma	0.000237	0.000251	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—AKT1—meningioma	0.000237	0.00025	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—AKT1—meningioma	0.000235	0.000248	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—AKT1—meningioma	0.000234	0.000248	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—AKT1—meningioma	0.000233	0.000247	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—ERBB2—meningioma	0.000231	0.000245	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALAD—meningioma	0.000229	0.000242	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—PTEN—meningioma	0.000227	0.000241	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—AKT1—meningioma	0.000225	0.000239	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HES1—meningioma	0.000225	0.000238	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000225	0.000238	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PDGFB—meningioma	0.000223	0.000236	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TSHB—meningioma	0.000222	0.000235	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HES1—meningioma	0.000222	0.000235	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—meningioma	0.000221	0.000235	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—ERBB2—meningioma	0.000214	0.000226	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—PTEN—meningioma	0.000213	0.000226	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000211	0.000224	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—AKT1—meningioma	0.000211	0.000224	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—meningioma	0.000205	0.000217	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—AKT1—meningioma	0.000203	0.000215	CbGpPWpGaD
Isoprenaline—MAPK1—Platelet activation, signaling and aggregation—AKT1—meningioma	0.0002	0.000212	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—ERBB2—meningioma	0.0002	0.000211	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—PTEN—meningioma	0.000197	0.000209	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—ERBB2—meningioma	0.000197	0.000208	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PDGFB—meningioma	0.000192	0.000204	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PDGFB—meningioma	0.00019	0.000201	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TSHB—meningioma	0.00019	0.000201	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SMO—meningioma	0.000189	0.0002	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—ERBB2—meningioma	0.000189	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—AKT1—meningioma	0.000187	0.000198	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TSHB—meningioma	0.000185	0.000196	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ERBB2—meningioma	0.000184	0.000195	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HES1—meningioma	0.000182	0.000193	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ERBB2—meningioma	0.000181	0.000192	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PGR—meningioma	0.000181	0.000192	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—meningioma	0.000179	0.00019	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HES1—meningioma	0.000178	0.000188	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HES1—meningioma	0.000177	0.000187	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—PTEN—meningioma	0.00017	0.00018	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—AKT1—meningioma	0.000168	0.000178	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—PTEN—meningioma	0.000168	0.000177	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—AKT1—meningioma	0.000166	0.000176	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PTEN—meningioma	0.000165	0.000175	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PDGFB—meningioma	0.000164	0.000174	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—AKT1—meningioma	0.000163	0.000172	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ERBB2—meningioma	0.000162	0.000171	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—AKT1—meningioma	0.000162	0.000171	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ERBB2—meningioma	0.000162	0.000171	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SMO—meningioma	0.000161	0.000171	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—PTEN—meningioma	0.000161	0.00017	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SMO—meningioma	0.000158	0.000167	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PTEN—meningioma	0.000157	0.000166	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PDGFB—meningioma	0.000156	0.000165	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PTEN—meningioma	0.000155	0.000164	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PGR—meningioma	0.000155	0.000164	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PDGFB—meningioma	0.000152	0.000161	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—AKT1—meningioma	0.000152	0.00016	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PDGFB—meningioma	0.000151	0.00016	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PGR—meningioma	0.000151	0.00016	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ERBB2—meningioma	0.000149	0.000158	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—AKT1—meningioma	0.000148	0.000157	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TSHB—meningioma	0.000148	0.000156	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PTEN—meningioma	0.000138	0.000146	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—PTEN—meningioma	0.000138	0.000146	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—AKT1—meningioma	0.000136	0.000144	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—AKT1—meningioma	0.000135	0.000143	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PTEN—meningioma	0.000132	0.000139	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—AKT1—meningioma	0.000131	0.000139	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB2—meningioma	0.000129	0.000137	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTEN—meningioma	0.000127	0.000135	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB2—meningioma	0.000127	0.000135	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HES1—meningioma	0.000124	0.000131	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—AKT1—meningioma	0.000123	0.00013	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—meningioma	0.000122	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—AKT1—meningioma	0.000118	0.000125	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—AKT1—meningioma	0.000116	0.000123	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—meningioma	0.000115	0.000122	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—meningioma	0.000114	0.00012	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PTEN—meningioma	0.00011	0.000116	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB2—meningioma	0.00011	0.000116	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PTEN—meningioma	0.000108	0.000115	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—meningioma	0.000107	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTEN—meningioma	0.000107	0.000113	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PDGFB—meningioma	0.000106	0.000112	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—meningioma	0.000106	0.000112	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HES1—meningioma	0.000106	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—meningioma	0.000105	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB2—meningioma	0.000105	0.000111	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HES1—meningioma	0.000103	0.000109	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—meningioma	0.000103	0.000109	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB2—meningioma	0.000102	0.000108	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB2—meningioma	0.000101	0.000107	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—meningioma	9.81e-05	0.000104	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—meningioma	9.66e-05	0.000102	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—meningioma	9.58e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—meningioma	9.51e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—meningioma	9.42e-05	9.97e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PTEN—meningioma	9.37e-05	9.92e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—meningioma	9.35e-05	9.9e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—meningioma	9.27e-05	9.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—meningioma	9.05e-05	9.59e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PDGFB—meningioma	9.03e-05	9.57e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	9.03e-05	9.56e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—meningioma	8.92e-05	9.44e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PTEN—meningioma	8.91e-05	9.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PDGFB—meningioma	8.84e-05	9.36e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PTEN—meningioma	8.7e-05	9.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—meningioma	8.7e-05	9.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTEN—meningioma	8.65e-05	9.16e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—meningioma	8.49e-05	8.99e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—meningioma	7.95e-05	8.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—meningioma	7.95e-05	8.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—meningioma	7.58e-05	8.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—meningioma	7.51e-05	7.95e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—meningioma	7.4e-05	7.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—meningioma	7.34e-05	7.77e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB2—meningioma	7.11e-05	7.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—meningioma	6.34e-05	6.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—meningioma	6.25e-05	6.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—meningioma	6.14e-05	6.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—meningioma	6.08e-05	6.44e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTEN—meningioma	6.06e-05	6.42e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB2—meningioma	6.06e-05	6.41e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—meningioma	5.94e-05	6.29e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB2—meningioma	5.92e-05	6.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—meningioma	5.91e-05	6.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—meningioma	5.55e-05	5.87e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—meningioma	5.43e-05	5.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—meningioma	5.4e-05	5.72e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTEN—meningioma	5.16e-05	5.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—meningioma	5.14e-05	5.44e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTEN—meningioma	5.05e-05	5.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—meningioma	5.04e-05	5.33e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—meningioma	5.01e-05	5.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—meningioma	4.99e-05	5.28e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—meningioma	4.93e-05	5.22e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—meningioma	4.14e-05	4.38e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTEN—meningioma	4.02e-05	4.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—meningioma	3.52e-05	3.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—meningioma	3.49e-05	3.7e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—meningioma	3.45e-05	3.65e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—meningioma	2.98e-05	3.15e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—meningioma	2.91e-05	3.08e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—meningioma	2.32e-05	2.45e-05	CbGpPWpGaD
